Pediatric Dermatology Perspective

• S2 Episode 3: Asthma Is a Genetic Disease. Why Does That Matter?   The field of asthma genetics and pharmacogenetics is rapidly evolving. What does that mean for patients experiencing asthma? Join Drs Michael Wechsler and Benjamin Raby as they discuss.
  Medscape, August 16, 2023
• Botox Training: Shortcut to Cash or Risky Business?   Healthcare pros join the Botox party trend, but are 2-day courses safe enough? Drs Patel and Watchmaker reveal the allure, risks, and skills required for this lucrative cosmetic cash action.
  Medscape Hospital Medicine, August 01, 2023
• SPD 2023 Read clinically focused news coverage of key developments from SPD 2023
  Medscape Dermatology, July 17, 2023
• S2 Episode 2: Does Your Patient Have Allergic Asthma?   Join Drs Mike Wechsler and Mario Castro as they discuss the diagnosis and treatment of allergic asthma in the clinic.
  Medscape, July 13, 2023
• WCD 2023 Read clinically focused news coverage of key developments from WCD 2023
  Medscape Dermatology, July 05, 2023
• S2 Episode 4: Oral Psoriasis Drugs: What Are NPs Prescribing?   Dr Steven R. Feldman and nurse practitioner Lakshi M. Aldredge discuss systemic therapy for psoriasis and how nurse practitioners and physician associates fill an important gap.
  Medscape, June 28, 2023
• Is Low Testosterone the Cause of Declining Sexual Function? It's common to think that testosterone replacement is the only cure for low libido in postmenopausal women, but it's more complicated. Other hormones can contribute to an unpleasant sexual experience.
  Medscape Diabetes & Endocrinology, June 26, 2023
• S2 Episode 3: Surfacing Synergistic Solutions for Limited Psoriasis   Drs Steven R. Feldman and Kim A. Papp discuss the expanding universe of opportunities and advances for halting limited psoriasis.
  Medscape, May 25, 2023
• S2 Episode 2: Can Psoriasis Care Limit CVD, PsA, and Depression?   Dr Steve Feldman speaks with Drs Mehta, Ritchlin, and Fried who share an exciting new roadmap for calming key psoriasis comorbidities.
  Medscape, April 25, 2023
• Atopic Dermatitis Highlights From AAD 2023   The safety of abrocitinib, data on IL-22 inhibition, and the link between atopic dermatitis (AD) and inflammatory bowel disease top the AD highlights from AAD 2023, as reported by Dr Joel Gelfand.
  Medscape, April 10, 2023
• AAD 2023 Read clinically focused news coverage of key developments from AAD 2023
  Medscape Dermatology, March 17, 2023
• S1 Episode 6: Challenges and Opportunities: Moderate to Severe Childhood Asthma   Drs Wechsler, Bacharier, and Phipatanakul discuss the challenges and opportunities in the field of moderate to severe childhood asthma.
  Medscape, December 06, 2022
• ISAD 2022 Read clinically focused news coverage of key developments from ISAD 2022.
  Medscape Dermatology, October 19, 2022
• Atopic Dermatitis Highlights From EADV 2022   Highlights in atopic dermatitis from EADV include efficacy of dupilumab in clinical practice, JAK inhibitors upadacitinib and baricitinib, and a 28-country assessment of AD burden of disease.
  Medscape, October 03, 2022
• 'I Shall Harm': When Patients Experience the Nocebo Effect Nocebo, from the Latin, "I shall harm," is the dark counterpart to the placebo, Jeffrey Benabio, MD, writes in his column.
  MDedge, August 12, 2022
• Diffuse Urticarial Eruptions After COVID-19 Vaccination Many common side effects of the COVID-19 vaccine are dermatologic. Dr Stadtmauer discusses seven patients he has treated personally.
  Medscape Allergy & Immunology, July 18, 2022
• BAD 2022 Read clinically focused news coverage of key developments from BAD 2022.
  Medscape Dermatology, July 07, 2022
• SPD 2022 Read clinically focused news coverage of key developments from SPD 2022.
  July 07, 2022
• A Golden Era of Atopic Dermatitis: New Therapies Address Unmet Needs   Jonathan Silverberg, MD, PhD, MPH, discusses exciting new oral, injectable, and topical therapies that have the potential to significantly alter the treatment landscape for atopic dermatitis.
  Medscape, June 29, 2022
• Management of Atopic Dermatitis: Bringing Therapy Into Focus   Saakshi Khattri, MD, recounts the evolution of treatments for atopic dermatitis (AD), from the widespread use of general immune suppressants such as methotrexate and cyclosporine, to more recent, targeted agents.
  Medscape, June 29, 2022